Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VICL

Vical (VICL) Stock Price, News & Analysis

Vical logo

About Vical Stock (NASDAQ:VICL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.68
$3.15
52-Week Range
N/A
Volume
35,024 shs
Average Volume
1.44 million shs
Market Capitalization
$21.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VICL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vical and its competitors with MarketBeat's FREE daily newsletter.

VICL Stock News Headlines

AI Frenzy Could Send ‘EarnPhone’ Soaring
The hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and searches — are feeding the next wave of AI innovation. Big Tech is harvesting it. Mode Mobile is giving it back to you. They are creating a user-powered data economy that shares the upside, and +50M users have already generated +$325M in earnings. This isn't a theory… Mode’s 32,481% revenue growth from 2019-2022 landed them the #1 spot on Deloitte’s 2023 list of fastest growing companies in software, and they’ve secured the Nasdaq ticker $MODE ahead of a potential IPO. The offering could close any moment now. AI breakthroughs are everywhere, but these models need your data to survive. Invest in the company that allows you to share in the profits from yours.
See More Headlines

VICL Stock Analysis - Frequently Asked Questions

Vical Incorporated (NASDAQ:VICL) released its quarterly earnings data on Tuesday, February, 19th. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.17). The biotechnology company had revenue of $0.12 million for the quarter, compared to analysts' expectations of $0.04 million. Vical had a negative net margin of 1,002.10% and a negative trailing twelve-month return on equity of 29.46%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vical investors own include Caladrius Biosciences (CLBS), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), Cytori Therapeutics (CYTX), Synergy Pharmaceuticals (SGYP), CTI BioPharma (CTIC) and Idera Pharmaceuticals (IDRA).

Company Calendar

Last Earnings
2/19/2019
Today
7/27/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:VICL
CIK
819050
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.25 million
Net Margins
-1,002.10%
Pretax Margin
N/A
Return on Equity
-29.46%
Return on Assets
-27.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
36.84
Quick Ratio
36.84

Sales & Book Value

Annual Sales
$1.62 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.82 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
22,840,000
Free Float
N/A
Market Cap
$21.01 million
Optionable
Not Optionable
Beta
0.32
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:VICL) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners